Nina Bhardwaj

27PUBLICATIONS
300CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMedical molecular engineering of nucleic acids and proteinsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 16, 2026
Dendritic cells control tertiary lymphoid structure development and maintenance in cancer.

|Jun 10, 2026
Leveraging cDC1 biology and function for enhanced immunotherapy.

|Feb 26, 2026
A Tumor-Promoting Inflammatory SPP1+ Macrophage-IL6-CRP Axis Drives Immune Dysfunction in Bladder Cancer.

Michelle A Tran, Byuri Angela Cho, Sudeh Izadmehr

|Feb 26, 2026
Improving peptide vaccine manufacturability without sacrificing immunogenicity: substitution of methionine and cysteine with oxidation-resistant isosteres.

Andrew S Ishizuka, Christopher M Garliss, Robert N Goddu

|Jul 28, 2025
Massively parallel immunopeptidome by DNA sequencing provides insights into cancer antigen presentation.

Quanming Shi, Elana P Simon, Cansu Cimen Bozkus

|Jul 02, 2025
Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applications.

Sreekumar Balan, Liam O'Brien, Ante Peros

Pageof 5

Frequent Collaborators

9 joint publications

Matthew D Galsky

8 joint publications

Sacha Gnjatic

7 joint publications

Thomas U Marron

6 joint publications

Miriam Merad